Search

everythinglearnresearchcommunity

for

Search:↓

Hair loss is a frequent long-term effect of COVID-19, and oral minoxidil is the most common effective treatment.

Older age, pre-existing skin conditions, cirrhosis, and pegylated interferon use increase the risk of skin issues during hepatitis C treatment.

Zinc supplementation may help improve treatment outcomes for chronic hepatitis C.

Immunomodulatory therapies are effective for treating cutaneous lymphoma, particularly in early stages.

Hair gels may cause split ends in children.

Current treatments for alopecia show no significant long-term benefits.

Some drugs can cause hair loss, change hair color and shape, or increase hair growth, and treatment may involve stopping the drug or using specific hair growth treatments.

Exosomes can improve skin health and offer new treatments for skin repair and rejuvenation.

Shrinking of oil glands in the skin is a key sign of hair loss linked to TNF inhibitor drugs and may improve if the treatment is stopped.

A 16-year-old boy with Castleman's disease and lupus was successfully treated and showed no recurrence.

Drug repositioning offers hope for new, affordable treatments for a genetic skin disorder called ARCI.

Men and women get COVID-19 at similar rates, but men tend to get sicker and have a higher risk of dying, while women usually have stronger immune responses and vaccine reactions.

Targeting and modifying the stem cell niche can improve regenerative therapies.

Skin cells release substances important for healing and fighting infection, and understanding these could improve skin disorder treatments.

Retinoids are effective for various skin conditions and hair loss but have serious side effects, so low doses are recommended.

PCOS causes infertility mainly due to hormonal imbalances, insulin resistance, and chronic inflammation.

A man's skin cancer improved and some of his hair grew back after treatment with a special light therapy and a medication.

Some treatments for autoimmune hair loss work, but JAK inhibitors like tofacitinib are promising for regrowth.

Melanocytes produce melanin; their defects cause vitiligo and hair graying, with treatments available for vitiligo.

Some drugs can cause skin reactions, which may improve when the drug is stopped, and rapid diagnosis and stopping the drug is crucial.

New insights into cell communication in psoriasis suggest innovative drug treatments.

CO2 laser treatment for aging skin significantly changes immune system-related genes.

IMA may indicate oxidative stress in skin and hair disorders, but more research is needed.

TNFα, IFNγ, and Substance P significantly affect prolactin levels in human skin, suggesting new treatments for skin and hair conditions.

A woman's hair loss during treatment with specific hepatitis C drugs grew back after stopping the medication.

A patient developed a blister at the injection site after hepatitis C treatment.

Blocking interferon-gamma might help treat various autoimmune diseases.

Plasmacytoid dendritic cells, which overproduce IFN-α, may play a crucial role in starting alopecia areata, an autoimmune disease causing hair loss.

New treatments for vitiligo may focus on protecting melanocyte stem cells from stress and targeting specific pathways involved in the condition.